Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2.

World journal of gastroenterology - 14 Feb 2006

Suzuki Hideyuki, Sato Ken, Takagi Hitoshi, Kanda Daisuke, Sohara Naondo, Kakizaki Satoru, Nakajima Hiroaki, Otsuka Toshiyuki, Nagamine Takeaki, Mori Masatomo

Abstract excerpt

AIM: The beneficial effect of zinc supplementation on the efficacy of interferon as a treatment for chronic hepatitis C had been demonstrated in hepatitis virus genotype 1b of high viral load. This study focused on patients with genotype 2, which is more sensitive to interferon than genotype 1b, and used consensus interferon (CIFN) with or without zinc. METHODS: We randomized 83 patients with chronic hepatitis C...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Interferons

Share to Liver Function Tests

Share to Organometallic Compounds

Source

Open in PubMed Open full text

Identifiers

PMID: 16521225
DOI: 10.3748/wjg.v12.i6.945
PMCID: PMC4066162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2.PMID 16521225Read ↗

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.Semantic proximity Read ↗

Preliminary study of combination therapy with interferon-alpha and zinc in chronic hepatitis C patients with genotype 1b.Semantic proximity Read ↗

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Can zinc enhance response interferon therapy for patients with HCV-related liver disease?Semantic proximity Read ↗

Zinc is a negative regulator of hepatitis C virus RNA replicationSemantic proximity Read ↗

Can zinc levels predict response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 4 infected Egyptian patients?Semantic proximity Read ↗

Randomized controlled trial of lymphoblastoid interferon alpha for chronic hepatitis C (comparison of 9-MU and 6-MU doses). IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine at Nagoya University School of Medicine.Semantic proximity Read ↗

Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2.Semantic proximity Read ↗

Effective interferon therapy for chronic hepatitis C patients with low viral loads.Semantic proximity Read ↗

An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.